Skip to main content
. 2019 Mar 1;14(3):e0211491. doi: 10.1371/journal.pone.0211491

Fig 6.

Fig 6

(a)Method Kaplan Meier. Kaplan-Meier estimated the survival time of the testing set patients using a risk score based on 5 mRNA signature. (b) Method Kaplan Meier. Kaplan-Meier estimated the survival time of the complete set patients from using a risk score based on 5 mRNA signature. The plot was used to visualize the survival probability for the low-risk versus high-risk group of patients based on the optimal cut-off point.